Skip to main content
Year archive

NUFORMIX PLC — 2025 filings

All 28 regulatory filings released by NUFORMIX PLC (NFX) in 2025, sourced directly from the official regulator.

28 Filings
2025 Period
2025 filings (28)
Filing Released Lang
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2025-11-28 English
Update re. US FDA ODD Application
Regulatory Filings
2025-11-12 English
Results of Underwritten Open Offer
Share Issue/Capital Change
2025-11-12 English
Circular - UNDERWRITTEN OPEN OFFER OF 114,040,535 OPEN OFFER SHARES AT 0.2 PENCE PER OPEN OFFER SHARE
Share Issue/Capital Change
2025-11-07 English
Underwritten Open Offer
Capital/Financing Update
2025-10-28 English
Change of Auditor
Board/Management Information
2025-10-10 English
European Respiratory Society Congress Attendance
Regulatory Filings
2025-09-25 English
US FDA ODD Application Submitted for NXP002
Legal Proceedings Report
2025-08-11 English
Total Voting Rights
Regulatory Filings
2025-05-30 English
Confirmation of European ODD for NXP002
Regulatory Filings
2025-05-29 English
Nuformix plc - Single prospectus
Capital/Financing Update
2025-05-28 English
Prospectus
Capital/Financing Update
2025-05-23 English
Publication of a Prospectus
Report Publication Announcement
2025-05-23 English
£210,000 Placing
Capital/Financing Update
2025-05-22 English
Attendance at American Thoracic Society Congress
Regulatory Filings
2025-05-19 English
Half-year Report
Interim / Quarterly Report H1 2025
2025-05-02 English
Confirmation of European Orphan Drug Designation
Regulatory Filings
2025-04-30 English
Change of Registered Office and Company Secretary
Regulatory Filings
2025-04-29 English
Correction - Exercise of Warrants
Share Issue/Capital Change
2025-04-14 English
Exercise of Warrants
Share Issue/Capital Change
2025-04-14 English
NXP002 Update
Regulatory Filings
2025-04-09 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2025-03-20 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2025-02-28 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement
2025-02-14 English
£168,750 Placing
Capital/Financing Update
2025-01-30 English
Annual Results for period ended 30 September 2024
Earnings Release FY 2024
2025-01-29 English
NXP002 ODD Application Submitted
Regulatory Filings
2025-01-28 English
NXP002 Orphan Drug Designation Draft Application
Regulatory Filings
2025-01-13 English